Paclitaxel-coated angioplasty balloon - Medtronic

Drug Profile

Paclitaxel-coated angioplasty balloon - Medtronic

Alternative Names: MDT 2113; Paclitaxel drug-eluting angioplasty balloon - Medtronic

Latest Information Update: 21 Nov 2016

Price : $50

At a glance

  • Originator Medtronic
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Peripheral arterial occlusive disorders

Most Recent Events

  • 01 Sep 2016 Medtronic completes a phase-II clinical trial in Peripheral arterial occlusive disorders in China (Intra-arterial) (NCT02118532)
  • 01 Mar 2014 Phase-II clinical trials in Peripheral arterial occlusive disorders in China (Intra-arterial)
  • 01 Jan 2014 Phase-II clinical trials in Peripheral arterial occlusive disorders in Japan (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top